NCT05559164View on ClinicalTrials.gov

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

March 1, 2027

Conditions
Cardiac ToxicityEarly-stage Breast Cancer
Interventions
DRUG

Lipitor 40mg Tablet

LIPITOR® (atorvastatin calcium) tablets will be administered orally as a single dose of 40 mg once daily, with or without food

Trial Locations (10)

07202

RECRUITING

Trinitas Hospital and Comprehensive Cancer Center, Elizabeth

08690

RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Hamilton

07097

RECRUITING

RWJBarnabas Health - - Jersey City Medical Medical, Jersey City

08701

RECRUITING

Monmouth Medical Center Southern Campus, Lakewood

07740

RECRUITING

RWJBarnabas Health - Monmouth Medical Center, Long Branch

07764

RECRUITING

Monmouth Community Medical, Long Branch

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

NOT_YET_RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

07112

RECRUITING

RWJBarnabas Health - Newark Beth Israel Medical Center, Newark

08873

RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER